New Jersey-based Catalent Inc. is a contract drug manufacturer that significantly increased its operations at the Monroe County location during the pandemic to meet the demand for COVID-19 vaccines. It's that same plant that the company blames in part for productivity issues and unexpected costs.... Read More
Eli Lilly and Co. has agreed to pay $13.5 million to settle class-action lawsuit that alleged Lilly systematically overpriced its insulin. The settlement covers older insulins in Lilly’s portfolio sold under the brand names Humalog, Humulin, and Basaglar. ... Read More
An Indianapolis-based radiopharmaceutical company said Friday it plans to help open a facility in Belgium to make therapeutic agents for European cancer patients.... Read More
Indianapolis-based VisionTech Angels has invested nearly $200,000 in NuvOx Pharma, a clinical stage biotechnology company in Tuscon, Arizona. NuvOx is developing what it calls a first-in-class oxygen therapeutic to treat life-threatening diseases.... Read More
A federal judge has tripled the damages in a jury verdict against Eli Lilly and Co., ruling that the drugmaker must pay $183.7 million in a lawsuit filed by a whistleblower who said the company made false claims about rebates to the federal Medicaid program.... Read More
Eli Lilly and Co., which has launched 19 drugs in the past nine years, helping it recover from a dry spell in which it lost patent protections on its top products more than a decade ago, became the most valuable publicly-traded drugmaker in the world.... Read More
The Fishers City Council on Monday night approved a project agreement for a developer to build a 100,000-square-foot building that will fill the remaining eight acres of available property at the Fishers Life Science & Innovation Park.... Read More
Cook Medical, the Bloomington-based maker of medical devices, said Monday it will cut 500 jobs, or about 4% of its global workforce, as part of a new strategic plan to refocus efforts on product innovation. The layoffs will affect about 223 workers in the U.S.... Read More
West Lafayette-based Inotiv Inc. is reporting a fiscal second quarter net loss of $10 million, compared to a loss of $6.1 million during the same period last year. Despite the loss, CEO Robert Leasure said the company is making progress with its ongoing site optimization initiatives.... Read More
The CEO of Warsaw-based OrthoWorx says a $30 million appropriation from the state's new two-year budget has created excitement within the state's orthopedic industry. The funding was provided to support efforts to attract and retain talent.... Read More
Illinois-based Baxter International Inc. this week announced plans divest its BioPharma Solutions business to Advent International and Warburg Pincus, private equity firms headquartered in Boston and New York, respectively, in a $4.25 billion deal. ... Read More
New Jersey-based Catalent is delaying the release of its fiscal third quarter earnings. Part of the reason for the delay, the company said, are "certain potential non-cash adjustments" related to its Bloomington operations.... Read More
A pair of traditional looking glasses that project subtitles for a deaf or hard of hearing person wearing them is the bold vision of two recent University of Notre Dame graduates. The duo has its first prototype and a startup that quickly raised $300,000..... Read More
Indianapolis-based Northwind Pharmaceuticals LLC has acquired QVI Risk Solutions, a health benefit administrator headquartered in Bend, Oregon. The private pharmaceutical repackaging company did not disclose financial details of the deal.... Read More
Eli Lilly and Co. says a new clinical trial for its drug tirzepatide helped overweight diabetes patients lose an average of 15.7% of body weight, or 34.4 pounds, after 72 weeks. The drug is currently sold under the brand name Mounjaro for type 2 diabetes... Read More
The Purdue Research Foundation said Wednesday it has received more than $100 million from Owl Rock in New York for a portion of its royalty interest in the prostate cancer drug Pluvicto. Purdue plans to use the funding to further support research at the university.... Read More
Eli Lilly and Co. plans to sell its drug to treat low blood sugar to California-based Amphastar Pharmaceuticals in a deal that could be worth up to $1.1 billion.... Read More
Purdue Ventures has invested $250,000 in TRIO Pharmaceuticals Inc., an antibody-based cancer therapeutics company founded by a Purdue University biophysics and structural biology alumnus. ... Read More
The state's life sciences sector accessed more than $6.8 billion in capital investment in 2022, according to a new report from BioCrossroads. The state's life sciences initiative said the investment will directly result in the creation of 3,000 new jobs.... Read More
A biotech startup that has raised $6 million to develop a highly purified form of collagen used to support tissue generation plans to hire 43 people and stands to get a six-year tax abatement worth more than a quarter-million dollars.... Read More
